LOS ANGELES--(BUSINESS WIRE)-- Kernel, a leader in non-invasive neuroimaging, announces the publication of their study "Measuring acute effects of subanesthetic ketamine on cerebrovascular ...
LOS ANGELES--(BUSINESS WIRE)--Kernel, an innovator in non-invasive neuroimaging technology, announces the first patient has been measured in an observational study of depression treatments using ...
- Results to be presented at PSYCH Symposium taking place in London on May 11, 2022 - LOS ANGELES & TORONTO--(BUSINESS WIRE)--Kernel, a leader in non-invasive neuroimaging, and Cybin Inc. (NEO:CYBN) ...
Are two sets of data genuinely different, or is it because of randomness? This question, known as the two-sample testing ...
Please provide your email address to receive an email when new articles are posted on . Neurotechnology firm Kernel and biopharmaceutical company Cybin announced promising pilot results from a ...
Bryan Johnson founded Kernel to offer neurodata acquisition and analytics services at an affordable price. Bryan Johnson says his “secret weapon” when it came to launching neurotech company Kernel was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results